These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34503847)

  • 1. From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?
    Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Holm J; Bjørnholt SM; Jensen PT
    Gynecol Oncol; 2021 Nov; 163(2):281-288. PubMed ID: 34503847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
    Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Vilstrup MH; Bjørnholt SM; Jensen PT
    Gynecol Oncol; 2021 Sep; 162(3):546-554. PubMed ID: 34226018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
    Holm J; Gerke O; Vilstrup MH; Spasojevic D; Sponholtz SE; Jochumsen KM; Thomassen A; Hildebrandt MG; Jensen PT
    Gynecol Oncol; 2022 Nov; 167(2):152-158. PubMed ID: 36182533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
    Lührs O; Ekdahl L; Geppert B; Lönnerfors C; Persson J
    Gynecol Oncol; 2021 Nov; 163(2):289-293. PubMed ID: 34509298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualization of surgical management of cervical cancer stages IA1, IA2.
    Pichlík T; Rob L; Robová H; Halaška MJ; Drozenová J; Hruda M; Drochýtek V
    Ceska Gynekol; 2019; 84(3):172-176. PubMed ID: 31324105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Santoro A; Angelico G; Inzani F; Arciuolo D; Spadola S; Valente M; D'Alessandris N; Piermattei A; Fiorentino V; CIanfrini F; Bizzarri N; Pedone Anchora L; Fagotti A; Scambia G; Zannoni GF
    Int J Gynecol Cancer; 2020 Dec; 30(12):1871-1877. PubMed ID: 33127865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy.
    Narayan K; McKenzie AF; Hicks RJ; Fisher R; Bernshaw D; Bau S
    Int J Gynecol Cancer; 2003; 13(5):657-63. PubMed ID: 14675351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer.
    Widschwendter P; Janni W; Scholz C; De Gregorio A; De Gregorio N; Friedl TWP
    Arch Gynecol Obstet; 2019 Dec; 300(6):1709-1718. PubMed ID: 31696367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer.
    Balaya V; Bresset A; Guani B; Magaud L; Montero Macias R; Delomenie M; Bonsang-Kitzis H; Ngô C; Bats AS; Mathevet P; Lécuru F
    Gynecol Oncol; 2020 Jan; 156(1):93-99. PubMed ID: 31839343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.
    Roman LD; Felix JC; Muderspach LI; Varkey T; Burnett AF; Qian D; Morrow CP
    Gynecol Oncol; 1998 Mar; 68(3):220-5. PubMed ID: 9570969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.
    Ronsini C; Anchora LP; Restaino S; Fedele C; Arciuolo D; Teodorico E; Bizzarri N; Zannoni GF; Ferrandina G; Scambia G; Fanfani F
    Gynecol Oncol; 2021 Aug; 162(2):299-307. PubMed ID: 34116834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard?
    Gortzak-Uzan L; Jimenez W; Nofech-Mozes S; Ismiil N; Khalifa MA; Dubé V; Rosen B; Murphy J; Laframboise S; Covens A
    Gynecol Oncol; 2010 Jan; 116(1):28-32. PubMed ID: 19875161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain.
    Salvo G; Odetto D; Pareja R; Frumovitz M; Ramirez PT
    Int J Gynecol Cancer; 2020 Jun; 30(6):873-878. PubMed ID: 32241876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
    Papadia A; Gasparri ML; Genoud S; Bernd K; Mueller MD
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2275-2281. PubMed ID: 28669052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
    Knoth J; Pötter R; Jürgenliemk-Schulz IM; Haie-Meder C; Fokdal L; Sturdza A; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Wiebe E; Rai B; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Sundset M; Tan LT; Nout RA; Tanderup K; Kirisits C; Nesvacil N; Lindegaard JC; Schmid MP
    Gynecol Oncol; 2020 Oct; 159(1):136-141. PubMed ID: 32798000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential risks in sentinel lymph node biopsy for cervical cancer: a single-institution pilot study.
    Tu H; Wan T; Zhang X; Gu H; Feng Y; Huang H; Liu J
    World J Surg Oncol; 2020 Jun; 18(1):133. PubMed ID: 32552905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.